{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:32:27Z","timestamp":1782797547948,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Child and Adolescent Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.chc.2008.07.009","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T07:25:30Z","timestamp":1226993130000},"page":"175-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Pharmacotherapy for Eating Disorders and Obesity"],"prefix":"10.1016","volume":"18","author":[{"given":"Pauline S.","family":"Powers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Bruty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chc.2008.07.009_bib1","series-title":"Clinical manual of eating disorders","first-page":"127","article-title":"Management of anorexia nervosa in an ambulatory setting","author":"Kaplan","year":"2007"},{"issue":"2","key":"10.1016\/j.chc.2008.07.009_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-3223(99)00014-1","article-title":"Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action","volume":"46","author":"Delgado","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.chc.2008.07.009_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0006-3223(00)01013-1","article-title":"Double-blind placebo-controlled administration of fluoxetine in restricting type anorexia nervosa","volume":"49","author":"Kaye","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"22","key":"10.1016\/j.chc.2008.07.009_bib4","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/jama.295.22.2605","article-title":"Fluoxetine after weight restoration in anorexia nervosa: a randomized, placebo-controlled trial","volume":"295","author":"Walsh","year":"2006","journal-title":"JAMA"},{"issue":"87","key":"10.1016\/j.chc.2008.07.009_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1192\/S000712500026354X","article-title":"Olanzapine in the treatment of anorexia nervosa","volume":"175","author":"Hansen","year":"1999","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2008.07.009_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/(SICI)1098-108X(200004)27:3<363::AID-EAT16>3.0.CO;2-5","article-title":"Case reports of olanzapine treatment of anorexia nervosa","volume":"27","author":"La Via","year":"2000","journal-title":"Int J Eat Disord"},{"issue":"2","key":"10.1016\/j.chc.2008.07.009_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/eat.10084","article-title":"Olanzapine in the treatment of anorexia nervosa: an open label trial","volume":"32","author":"Powers","year":"2002","journal-title":"Int J Eat Disord"},{"issue":"11","key":"10.1016\/j.chc.2008.07.009_bib8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v65n1106","article-title":"An open trial of olanzapine in anorexia nervosa","volume":"65","author":"Barbarich","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2008.07.009_bib9","first-page":"197","article-title":"Olanzapine therapy in anorexia nervosa psychobiological effects","volume":"22","author":"Brambilla","year":"2007","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.chc.2008.07.009_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","article-title":"Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: A randomized, double-blind, placebo-controlled trial","volume":"165","author":"Bissada","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2008.07.009_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/gut.34.2.166","article-title":"Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa","volume":"34","author":"Stacher","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.chc.2008.07.009_bib12","first-page":"898","article-title":"The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa","volume":"80","author":"Klibanski","year":"1995","journal-title":"J Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.chc.2008.07.009_bib13","first-page":"97","article-title":"Osteopenia and osteoporosis in anorexia nervosa","volume":"14","author":"Golden","year":"2003","journal-title":"Adolesc Med"},{"issue":"1","key":"10.1016\/j.chc.2008.07.009_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/eje.0.1460045","article-title":"The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa","volume":"146","author":"Munoz","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.chc.2008.07.009_bib15","series-title":"Clinical manual of eating disorders","first-page":"171","article-title":"Management of bulimia nervosa","author":"Mitchell","year":"2007"},{"issue":"2","key":"10.1016\/j.chc.2008.07.009_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0193-953X(05)70227-6","article-title":"Combining pharmacotherapy and psychotherapy in the treatment of patients with eating disorders","volume":"24","author":"Mitchell","year":"2001","journal-title":"Psychiatr Clin North Am"},{"issue":"1","key":"10.1016\/j.chc.2008.07.009_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ajp.149.1.82","article-title":"Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison","volume":"149","author":"Agras","year":"1992","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2008.07.009_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02850155","article-title":"Treatment of bulimia nervosa with sertraline: a randomized controlled trial","volume":"21","author":"Milano","year":"2004","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.chc.2008.07.009_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1992.01820020059008","article-title":"Fluoxetine in the treatment of bulimia nervosa: a multi-center, placebo-controlled double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group","volume":"49","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2008.07.009_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/104454603322572660","article-title":"An open trial of fluoxetine for adolescents with bulimia nervosa","volume":"13","author":"Kotler","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"10.1016\/j.chc.2008.07.009_bib21","first-page":"262","article-title":"Treatment of bulimia with bupropion: a multicenter controlled trial","volume":"49","author":"Horne","year":"1988","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.chc.2008.07.009_bib22","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4088\/JCP.v64n1208","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures","volume":"64","author":"Hedges","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.chc.2008.07.009_bib23","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge purge measures","volume":"64","author":"Hoopes","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2008.07.009_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","article-title":"Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Nickel","year":"2005","journal-title":"Int J Eat Disord"},{"issue":"10","key":"10.1016\/j.chc.2008.07.009_bib25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archpsyc.1997.01830220099014","article-title":"Treatment of bulimia nervosa with ondansetron","volume":"54","author":"Hartman","year":"1997","journal-title":"Arch Gen psychiatry"},{"issue":"9206","key":"10.1016\/j.chc.2008.07.009_bib26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0140-6736(99)09062-5","article-title":"Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomized, double-blind trial","volume":"355","author":"Faris","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.chc.2008.07.009_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00005053-199106000-00008","article-title":"Treatment of bulimia nervosa with lithium carbonate: a controlled study","volume":"179","author":"Hsu","year":"1991","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"10.1016\/j.chc.2008.07.009_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1098-108X(199704)21:3<299::AID-EAT11>3.0.CO;2-W","article-title":"Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report","volume":"21","author":"Schweickert","year":"1997","journal-title":"Int J Eat Disord"},{"issue":"10","key":"10.1016\/j.chc.2008.07.009_bib29","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jada.2007.07.017","article-title":"Weight-loss outcomes: a systematic review and meta-anaysis of weight-loss clinical trials with a minimum 1-year follow-up","volume":"107","author":"Franz","year":"2007","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.chc.2008.07.009_bib30","series-title":"The Stoplight Diet for children","author":"Epstein","year":"1988"},{"issue":"14","key":"10.1016\/j.chc.2008.07.009_bib31","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/jama.289.14.1805","article-title":"Behavior therapy and sibutramine for the treatment of adolescent obesity","volume":"289","author":"Berkowitz","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.chc.2008.07.009_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-145-2-200607180-00005","article-title":"Effects of sibutramine treatment in obese adolescents","volume":"145","author":"Berkowitz","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.chc.2008.07.009_bib33","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1542\/peds.2006-2137","article-title":"Cardiovascular effects of sibutramine in the treatment of adolescents: results of a randomized, double-blind, placebo-controlled study","volume":"120","author":"Daniels","year":"2007","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.chc.2008.07.009_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.JCN.0000278959.75253.1d","article-title":"Weight loss in obese African American and Caucasian adolescents","volume":"22","author":"Budd","year":"2007","journal-title":"J Cardiovasc Nurs"},{"issue":"5","key":"10.1016\/j.chc.2008.07.009_bib35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.clinthera.2006.05.008","article-title":"Use of sibutramine in obese Mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled parallel-group trial","volume":"28","author":"Garcia-Morales","year":"2006","journal-title":"Clin Ther"},{"issue":"9","key":"10.1016\/j.chc.2008.07.009_bib36","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1345\/aph.1K022","article-title":"Pharmacotherapeutic options for overweight adolescents","volume":"41","author":"Dunican","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.chc.2008.07.009_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1515\/JPEM.2004.17.3.307","article-title":"Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions","volume":"17","author":"McDuffie","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.chc.2008.07.009_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.ijo.0802281","article-title":"Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity","volume":"27","author":"Krempf","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"6","key":"10.1016\/j.chc.2008.07.009_bib39","first-page":"32","article-title":"Weighing Allis's impact. Eating disorder patients might be tempted to abuse the first FDA-approved nonprescription diet pill","volume":"27","author":"Cumella","year":"2007","journal-title":"Behav Healthc"},{"issue":"4","key":"10.1016\/j.chc.2008.07.009_bib40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/eat.1108","article-title":"Bulimia nervosa and misuse of orlistat: two case reports","volume":"30","author":"Fernandez-Aranda","year":"2001","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.chc.2008.07.009_bib41","doi-asserted-by":"crossref","unstructured":"Curioni C, Andr\u00e9 C. Rimonabant for overweight or obesity. Cochrane Database Syst Rev 2006;4:CD006. 10.1002\/14651858.CD006162.pub2.","DOI":"10.1002\/14651858.CD006162"},{"issue":"1","key":"10.1016\/j.chc.2008.07.009_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/jc.2002-021033","article-title":"Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients","volume":"88","author":"Freemark","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.chc.2008.07.009_bib43","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2006-0241","article-title":"Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: Improvement in body composition and fasting insulin","volume":"91","author":"Srinivasan","year":"2006","journal-title":"J Clin Endocrinol Meta"},{"issue":"4","key":"10.1016\/j.chc.2008.07.009_bib44","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1542\/peds.107.4.e55","article-title":"The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes","volume":"107","author":"Freemark","year":"2001","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.chc.2008.07.009_bib45","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/oby.2004.151","article-title":"Current and investigational antiobesity agents and obesity therapeutic treatment targets","volume":"12","author":"Bays","year":"2004","journal-title":"Obes Res"},{"key":"10.1016\/j.chc.2008.07.009_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1467-789X.2007.00424.x","article-title":"Molecular network of obesity: what does it promise for pharmacotherapy","volume":"9","author":"Myslobodsky","year":"2008","journal-title":"Obes Rev"}],"container-title":["Child and Adolescent Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105649930800059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105649930800059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:37:56Z","timestamp":1760999876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105649930800059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S105649930800059X"],"URL":"https:\/\/doi.org\/10.1016\/j.chc.2008.07.009","relation":{},"ISSN":["1056-4993"],"issn-type":[{"value":"1056-4993","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy for Eating Disorders and Obesity","name":"articletitle","label":"Article Title"},{"value":"Child and Adolescent Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chc.2008.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}